Amiloride Hydrochloride/Spironolactone
盐酸阿米洛利/螺内酯
Report date: 2022/02/14 09:57:12
Base Information
Drug NameAmiloride Hydrochloride/Spironolactone
Drug Alias Name +[15]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes SpironolactoneAmiloride Hydrochloride
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Alabama
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesHemodynamic TherapeuticsUniversity Of Alabama
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A